Proteomics can be defined as the study of proteomes. Proteomes are a set of proteins which are produced in a system, organism, or any biological context. Proteomes vary from cell to cell and changes over a period of time. Proteomics is used in various applications, such as, to investigate protein expression, in transcriptional and post transcriptional studies, metabolic pathways, to study protein interaction in diseases viz. cancer, to study localization of sub cellular proteins, etc. Proteomics can be studied using various technologies, such as, mass spectrometry, gel-based techniques, and others.
The global proteomics market is expected to grow at a significant CAGR during the forecast period. Increasing research & development activities in the healthcare industries, rising demand for personalized medicines, and increasing activities of drug discovery are some of the important factors expected to contribute to the growth of the global proteomics market during the forecast period. Rise in use of proteomics to study cancer genes and protein interaction in cancer genes is projected to drive the growth of the global proteomics market due to high prevalence of cancer across the world. Factors such as application of proteomics in the diagnosis of infectious diseases, technological advancement, increase in health care expenditure, rise in awareness, etc. are the other factors likely to boost the growth of the global proteomics market during the forecast period. However, inadequate funding and lack of awareness regarding the application of proteomics in developing countries are anticipated to restrain the growth of global proteomics market during the forecast period.
The global proteomics market can be segmented on the basis of product, services, application, and region. Based on product, the global proteomics market can be divided into instrumentation and reagents. The instrumentation segment can be further classified into spectrometry, chromatography, X-ray, immunoassay, electrophoresis, and others. In terms of services, the global market can be segmented into analytical laboratory services, sequencing, protein identification, bioinformatics, and others. The anatomical laboratory services segment is expected to hold a significant share of the market during the forecast period due to effectiveness of services provided by anatomical laboratories in diagnosis and drug discovery. On the basis of application, the global proteomics market can be categorized into clinical diagnosis, drug discovery, and others. The clinical diagnosis segment is expected to hold a significant share of the market during the forecast period due to rise in prevalence of cancer, increase in incidence of infectious diseases, etc. across the globe.
The global proteomics market is expected to grow at significant rate in all geographical regions. Based on region, the global market can be segmented into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America. North America is expected to dominate the global proteomics market throughout the forecast period. Factors influencing the growth of market in North America include rise in funding from government, increase in research activities, high awareness regarding applications of proteomics, improved health care infrastructure, high health care expenditure, and rise in prevalence of cancer in the region. Europe is projected to be the second leading market for proteomics during the forecast period due to increase in cancer research activities, high funding from the government, and presence of key market players in the region. Driver The proteomics market in Asia Pacific is estimated to expand at a significantly high CAGR during the forecast period. Growth drivers of the proteomics market in the region include high prevalence of cancer, rising health care expenditure, presence of a large number of drug manufactures in countries such as India and Japan leading to increase in drug discovery, and high prevalence of infectious diseases in the region.
In order to maintain a significant position in the global proteomics market, key players are adopting strategies, such as, mergers & acquisitions, geographical expansion, research & development, etc. Leading players operating in the global proteomics market include GE Healthcare, Bio-Rad Laboratories, Inc., Danaher Corporation, and PerkinElmer, Inc.
This study by TMR is all-encompassing framework of the dynamics of the market. It mainly comprises critical assessment of consumers' or customers' journeys, current and emerging avenues, and strategic framework to enable CXOs take effective decisions.
Our key underpinning is the 4-Quadrant Framework EIRS that offers detailed visualization of four elements:
- Customer Experience Maps
- Insights and Tools based on data-driven research
- Actionable Results to meet all the business priorities
- Strategic Frameworks to boost the growth journey
The study strives to evaluate the current and future growth prospects, untapped avenues, factors shaping their revenue potential, and demand and consumption patterns in the global market by breaking it into region-wise assessment.
The following regional segments are covered comprehensively:
- North America
- Asia Pacific
- Latin America
- The Middle East and Africa
The EIRS quadrant framework in the report sums up our wide spectrum of data-driven research and advisory for CXOs to help them make better decisions for their businesses and stay as leaders.
Below is a snapshot of these quadrants.
1. Customer Experience Map
The study offers an in-depth assessment of various customers’ journeys pertinent to the market and its segments. It offers various customer impressions about the products and service use. The analysis takes a closer look at their pain points and fears across various customer touchpoints. The consultation and business intelligence solutions will help interested stakeholders, including CXOs, define customer experience maps tailored to their needs. This will help them aim at boosting customer engagement with their brands.
2. Insights and Tools
The various insights in the study are based on elaborate cycles of primary and secondary research the analysts engage with during the course of research. The analysts and expert advisors at TMR adopt industry-wide, quantitative customer insights tools and market projection methodologies to arrive at results, which makes them reliable. The study not just offers estimations and projections, but also an uncluttered evaluation of these figures on the market dynamics. These insights merge data-driven research framework with qualitative consultations for business owners, CXOs, policy makers, and investors. The insights will also help their customers overcome their fears.
3. Actionable Results
The findings presented in this study by TMR are an indispensable guide for meeting all business priorities, including mission-critical ones. The results when implemented have shown tangible benefits to business stakeholders and industry entities to boost their performance. The results are tailored to fit the individual strategic framework. The study also illustrates some of the recent case studies on solving various problems by companies they faced in their consolidation journey.
4. Strategic Frameworks
The study equips businesses and anyone interested in the market to frame broad strategic frameworks. This has become more important than ever, given the current uncertainty due to COVID-19. The study deliberates on consultations to overcome various such past disruptions and foresees new ones to boost the preparedness. The frameworks help businesses plan their strategic alignments for recovery from such disruptive trends. Further, analysts at TMR helps you break down the complex scenario and bring resiliency in uncertain times.
The report sheds light on various aspects and answers pertinent questions on the market. Some of the important ones are:
1. What can be the best investment choices for venturing into new product and service lines?
2. What value propositions should businesses aim at while making new research and development funding?
3. Which regulations will be most helpful for stakeholders to boost their supply chain network?
4. Which regions might see the demand maturing in certain segments in near future?
5. What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
6. Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
7. Which government regulations might challenge the status of key regional markets?
8. How will the emerging political and economic scenario affect opportunities in key growth areas?
9. What are some of the value-grab opportunities in various segments?
10. What will be the barrier to entry for new players in the market?
Note: Although care has been taken to maintain the highest levels of accuracy in TMR’s reports, recent market/vendor-specific changes may take time to reflect in the analysis.